Open AccessOR16-5 Riluzole suppresses growth and enhances response to endocrine therapy in ER+ breast cancer
Author(s) -
Shaymaa Bahnassy,
Carlos Alberto Velasco Benítez,
M Idalia Cruz,
Yanira Guerra,
Shihong Ma,
Sonali Persaud,
Ganesh V. Raj,
Rebecca B. Riggins,
Hillary Stires,
Ayodeji Olukoya
Publication year - 2022
Publication title -
journal of the endocrine society
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.046
H-Index - 20
ISSN - 2472-1972
DOI - 10.1210/jendso/bvac150.1822
Subject(s) - riluzole , tamoxifen , breast cancer , estrogen receptor , medicine , endocrine system , fulvestrant , oncology , cancer , cancer research , estrogen , anastrozole , estrogen receptor alpha , endocrinology , hormone , receptor , glutamate receptor
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom